215 related articles for article (PubMed ID: 10442692)
21. Improvement of Predictivity of Teicoplanin Serum Trough Concentrations at Steady State Calculated by Vancomycin Pharmacokinetic Parameter.
Kobayashi R; Otomo S; Shiba Y; Ebinuma K; Sudoh T
Yakugaku Zasshi; 2016; 136(11):1557-1562. PubMed ID: 27803487
[TBL] [Abstract][Full Text] [Related]
22. [Predictive performance of population pharmacokinetic software on vancomycin steady-state trough concentration].
Xue S; Lu H; Tang L; Fang J; Shi L; Li J; Yu Y; Zhou Q; Xue S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):50-55. PubMed ID: 32148231
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients.
del Mar Fernández de Gatta Garcia M; Revilla N; Calvo MV; Domínguez-Gil A; Sánchez Navarro A
Intensive Care Med; 2007 Feb; 33(2):279-85. PubMed ID: 17165021
[TBL] [Abstract][Full Text] [Related]
24. High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures.
Pea F; Porreca L; Baraldo M; Furlanut M
J Antimicrob Chemother; 2000 Mar; 45(3):329-35. PubMed ID: 10702552
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Vancomycin Prediction Methods Based on Estimated Creatinine Clearance or Trough Levels.
Haeseker M; Croes S; Neef C; Bruggeman C; Stolk L; Verbon A
Ther Drug Monit; 2016 Feb; 38(1):120-6. PubMed ID: 26418699
[TBL] [Abstract][Full Text] [Related]
26. [PK/PD of vancomycin in patients with severe acute pancreatitis combined with augmented renal clearance].
He J; Mao E; Jing F; Jiang H; Xu W; Yang W; Chen E
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Sep; 29(9):810-814. PubMed ID: 28936957
[TBL] [Abstract][Full Text] [Related]
27. Vancomycin pharmacokinetics and Bayesian estimation in pediatric patients.
Wrishko RE; Levine M; Khoo D; Abbott P; Hamilton D
Ther Drug Monit; 2000 Oct; 22(5):522-31. PubMed ID: 11034256
[TBL] [Abstract][Full Text] [Related]
28. Development of a Population Pharmacokinetic Model of Vancomycin and its Application in Chinese Geriatric Patients with Pulmonary Infections.
Zhou Y; Gao F; Chen C; Ma L; Yang T; Liu X; Liu Y; Wang X; Zhao X; Que C; Li S; Lv J; Cui Y; Yang L
Eur J Drug Metab Pharmacokinet; 2019 Jun; 44(3):361-370. PubMed ID: 30506225
[TBL] [Abstract][Full Text] [Related]
29. Urea kinetics and dialysis treatment time predict vancomycin elimination during high-flux hemodialysis.
Schaedeli F; Uehlinger DE
Clin Pharmacol Ther; 1998 Jan; 63(1):26-38. PubMed ID: 9465839
[TBL] [Abstract][Full Text] [Related]
30. Predictive performance of a vancomycin-aminoglycoside population model.
Beringer PM; Wong-Beringer A; Rho JP
Ann Pharmacother; 1998 Feb; 32(2):176-81. PubMed ID: 9496400
[TBL] [Abstract][Full Text] [Related]
31. A Larger Dose of Vancomycin Is Required in Adult Neurosurgical Intensive Care Unit Patients Due to Augmented Clearance.
Lin Wu FL; Liu SS; Yang TY; Win MF; Lin SW; Huang CF; Wang KC; Shen LJ
Ther Drug Monit; 2015 Oct; 37(5):609-18. PubMed ID: 25627406
[TBL] [Abstract][Full Text] [Related]
32. Accuracy of predicting the vancomycin concentration in Japanese cancer patients by the Sawchuk-Zaske method or Bayesian method.
Nakashima T; Ohno T; Koido K; Hashimoto H; Terakado H
J Oncol Pharm Pract; 2020 Apr; 26(3):543-548. PubMed ID: 31142231
[TBL] [Abstract][Full Text] [Related]
33. Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
Abdel Hadi O; Al Omar S; Nazer LH; Mubarak S; Le J
J Oncol Pharm Pract; 2016 Jun; 22(3):448-53. PubMed ID: 26079639
[TBL] [Abstract][Full Text] [Related]
34. Population Pharmacokinetics and Pharmacodynamic Target Attainment of Vancomycin in Neonates on Extracorporeal Life Support.
Cies JJ; Moore WS; Nichols K; Knoderer CA; Carella DM; Chopra A
Pediatr Crit Care Med; 2017 Oct; 18(10):977-985. PubMed ID: 28650363
[TBL] [Abstract][Full Text] [Related]
35. Vancomycin pharmacokinetic and pharmacodynamic models for critically ill patients with post-sternotomy mediastinitis.
Mangin O; Urien S; Mainardi JL; Fagon JY; Faisy C
Clin Pharmacokinet; 2014 Sep; 53(9):849-61. PubMed ID: 25117184
[TBL] [Abstract][Full Text] [Related]
36. Correlation of aminoglycoside and vancomycin pharmacokinetic parameters.
Wragge TM; Cooper BE
Ann Pharmacother; 1993 Nov; 27(11):1346-8. PubMed ID: 8286806
[TBL] [Abstract][Full Text] [Related]
37. Comparison of two methods to obtain a desired first isepamicin peak in intensive care patients.
Fauvelle F; Coulaud JM; Lecointre K; Tardy D; Poussel JF; Trape G
Fundam Clin Pharmacol; 2001 Apr; 15(2):151-6. PubMed ID: 11468025
[TBL] [Abstract][Full Text] [Related]
38. Predictive performance of reported population pharmacokinetic models of vancomycin in Chinese adult patients.
Deng C; Liu T; Wu K; Wang S; Li L; Lu H; Zhou T; Cheng D; Zhong X; Lu W
J Clin Pharm Ther; 2013 Dec; 38(6):480-9. PubMed ID: 24033587
[TBL] [Abstract][Full Text] [Related]
39. [Pharmacokinetics of vancomycin in patients with severe acute pancreatitis and its influencing factors: analysis of 7 years data].
He J; Mao E; Jing F; Jiang H; Yang W; Chen E
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jun; 29(6):491-495. PubMed ID: 28625235
[TBL] [Abstract][Full Text] [Related]
40. Clinical Pharmacokinetics of Vancomycin in Critically Ill Children.
Sridharan K; Al Daylami A; Ajjawi R; Al-Ajooz H; Veeramuthu S
Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):807-816. PubMed ID: 31301023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
